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There is growing interest in understanding quality of life (QOL) domains among non-
Hodgkin lymphoma (NHL) survivors, the sixth most common cancer in the United States
(NCI, 2012). Treatment modalities such as chemotherapy, biologic therapy, and stem cell
transplantation have improved survival of patients with NHL to an overall 5 year survival
rate of 68% (Horner, Reis, & Krapcho, 2011). Though the survival rate has increased, NHL
remains an illness that elicits concerns related to late and long-term effects that affect QOL.
A review describing QOL domains of older NHL survivors and the impact cancer has on
health found that most studies lacked a conceptual or theoretical framework and
representation of socio-demographic diversity, specifically age (Leak, Mayer & Smith,
2011). NHL research has focused primarily on examining the impact of NHL and treatment
on survivor’s QOL. Oerlemans et al (2011) systematically reviewed lymphoma studies and
found that having higher education, being married or living with a partner, and being male
are associated with higher QOL in various cancer populations including NHL.
QOL is a widely accepted outcome measure in cancer research, but little is known about the
moderating effect of age on QOL in NHL survivors. The aging population in the US will
increase in numbers while NHL incidence rates are expected to rise. We need to better
understand the interface of age on overall QOL and its determinants. Studies have focused
on the moderator effects on QOL in lymphoma survivors including aerobic exercise
training,, gender, general health, and body mass index (BMI) (Courneya, 2011). It is likely
that age affects (moderates) the nature of relationships between other demographic and
disease characteristics and QOL.
Moderators are independent variables that affect the strength and/or direction of the
association between another independent variable and the outcome variable and help to
determine when the relationship occurs (Bennett, 2000). Studies have evaluated the impact
of sociodemographic and disease characteristics on QOL, however there are limited
published reports in the NHL literature to provide insight for clinicians and researchers on
the moderated effect of age and its association with QOL. Addressing the age association
with personal characteristics could assist clinicians in identifying patients in where
individualization of age appropriate cancer care is recommended. The role of age in the
association between determinants and QOL has not been investigated in this population,
therefore, nursing research can be focused on age sensitive assessments. Without keen
assessments, it is difficult to offer interventions to make appropriate resources available
without ongoing systematic assessments. The purpose of this study was to explore the
relationship of demographic and disease characteristics to QOL and to examine the
moderating effect of age among NHL survivors.
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A cancer survivor adaptation (CSA) model of QOL guided this study (Naus, Ishler, Parrott
& Kovacs, 2009). The three-component (personal characteristics, a moderator [age], and
outcomes) model proposes that personal characteristics (demographic and disease factors)
have a relationship with QOL and there is the potential that age may affect that relationship
or its strength. The outcome variable for this model is QOL. The CSA provided a theoretical
argument to move the NHL research beyond examining associations to explaining the
components of the model.
Methods
The sample was recruited through mailed surveys to individuals who were treated for NHL
from 2005 – 2006 at one of two comprehensive cancer centers in the southeastern United
States: Duke University and the University of North Carolina at Chapel Hill (UNC). Eligible
individuals were 18 years of age or older, at least two years post-diagnosis, and with or
without active disease. The response rate was 74% (Smith, Zimmerman, Williams, Preisser
& Clipp, 2008). This study was approved by the Duke and UNC Institutional Review
Boards. The current study is a secondary analysis of a cross-sectional study of NHL
survivors. The primary aim of the parent study was to estimate the prevalence of post-
traumatic stress disorder (PTSD) symptoms in survivors of adult NHL who were at least two
years post-diagnosis and to identify the risk factors associated with PTSD symptoms (Smith,
Zimmerman, Williams, Preisser & Clipp, 2008).
Instruments
Demographic and disease characteristics—Socio-demographic and disease-related
characteristics were self-reported obtained from the Tumor Registry. NHL type and stage
was provided from the Tumor Registry and the other demographics were self-reported.
Comorbidity was measured with the self-administered Comorbidity Questionnaire (SCQ)
(Sangha, Stucki, Liang, Fossel, & Katz, 2003). This questionnaire was used to assess past
and current health conditions including heart disease, high blood pressure, lung disease,
diabetes, ulcer or stomach disease, kidney disease, liver disease, anemia or other blood
disease, cancer other than lymphoma or non-melanoma skin cancer, depression,
osteoarthritis, degenerative arthritis, back pain, and rheumatoid arthritis. A binary answer
(yes-1 or no-0) was supplied for each question. The total comorbidity score ranged from 0 to
30 with higher scores indicating a greater comorbidity burden and lower scores indicating a
lower burden.
Quality of life outcome—The 27-item Functional Assessment of Cancer Therapy-
General (FACT-G, version 4) (Cella, Tulsky, Gray, et al, 1993; Cella, Webster & Cashy,
2005), was used to measure cancer-related QOL. A higher score indicates a higher
perception of QOL. The FACT-G scores ranges from 0–108. There are 4 well-being
domains that total a sum for FACT-G including FACT-Physical (FACT-PWB), FACT-
Social/Family (FACT-SFWB), FACT-Emotional (FACT-EWB), and FACT-Functional
(FACT-FWB). Evidence of satisfactory reliability and validity for FACT-G has been
reported in psychometric studies (Cella, Tulsky, Gray, et al, 1993; Cella, Webster & Cashy,
2005), and in the parent study, the reliability of the FACT-G total score was 0.93 (Smith,
Zimmerman, Williams, Preisser & Clipp, 2008).
Data Analysis
All analyses were conducted using SPSS 18.0. Multiple regression was used to analyze
relationships between demographic and disease characteristics, age, and QOL. The
Leak et al. Page 2













regression model included demographic and disease characteristics that were statistically
significant (all at p<.05) in bivariate analyses with QOL. Variables that were significant
were jointly entered into the model, and the final model only retained those predictors that
were significant at p<.05 (Table 3, Model 1). To test for moderation by age, the interaction
between each demographic and disease characteristic and age was added to the model
separately, and the significant interactions were jointly added to a single model (Table 3,
Model 2). All variables had <5% missing data except for cancer stage (13%) which was
therefore excluded from the analyses (Figure 1).
Results
Sample
The study sample included 741 NHL survivors who were, on average, 62.3 (SD 13.4) years
of age at the time of study. More than 40% were 65 years of age or older (n = 322), and 86%
were Caucasian. Over half (58%) were either retired or unemployed, and 27% earned less
than $30,000 annually. The mean time since diagnosis for the sample was 10.2 years (SD
7.1). (Table 1). Disease characteristics for the sample included 28% of survivors in Stage 1
and 24% in Stage 4. A majority (80%) reported having had chemotherapy, and about half
(48%) reported having had radiation as part of their treatment. The average total
comorbidity score was 5.6 (SD 4.8; scale ranged from 0–30). Most commonly reported
comorbidities were heart disease (19%), high blood pressure (18%), lung disease (17%), and
diabetes (14%). (Table 2).
As shown in Table 1, younger survivors (<65 years) were more likely than older survivors to
be of a minority race, college-educated, married or living with a partner, and employed.
Younger survivors also had higher annual income than older survivors. There were no age
differences for chemotherapy or radiation therapy, however younger survivors were more
likely to have received biologic therapy or a hematopoietic stem cell transplant than older
survivors. Comorbidities were more common in older survivors, with 28.3% having three or
more, compared to 23.3% in younger survivors.
Relationships of demographic and disease characteristics to QOL (Model 1)—
The associations between QOL and demographic/disease characteristics in the un-moderated
multiple regression model (Model 1) are provided in Table 2. The significant demographic
characteristics in this model were age, gender, annual income (<$30,000 vs. $30,000 +),
education (college graduate vs. not a college graduate), and employment status (employed
vs. not employed/retired). Significant disease characteristics were total comorbidity scores,
some treatment types (BMT/SCT or biologic therapy), and years since diagnosis. QOL was
worse for survivors who were males, younger at time of study, had a greater comorbidity
burden, had received a transplant or biologic therapy, or had been diagnosed more recently
(all at p <.05).
The FACT-G total mean score was 85.3 (16.9) with a range of 10–108 for this sample. The
QOL subscales mean scores were FACT_PWB 22.7 (range was 0–28), FACT_SFWB 22.2
(range 4–28), FACT_EWB 19.6 (range 0–24), and FACT_FWB 20.7 (range 0–28).
Compared to the overall cancer sample, NHL survivors had higher QOL mean scores on all
domains.(Table 4). Higher QOL was observed for females (1.87 points), college graduates
(2.47 points), and those who were employed (2.78 points), while earning less than $30,000
was associated with a 6.03 lower QOL score. In terms of disease characteristics, for every
point increase in comorbidity score, the FACT-G score was 1.35 points lower. Lower QOL
was also observed for those who were currently receiving treatment (4.84 points), and those
who had received a transplant (4.58 points) or biologic therapy (2.68 points). On the other
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hand, longer time since diagnosis was associated with a higher score (.16 point increase for
every year since diagnosis).
Moderating Effect of Age on QOL—Moderation of the relationships by age was
examined by adding the interaction between each disease/demographic characteristic and
age to Model 1, one at a time. There were two demographic characteristics/disease factors
whose relationships with QOL were moderated by age: income and gender (Figure 1). The
corresponding interaction terms were both included in the final model (Table 3, Model 2).
Moderation of the relationship between income and QOL remained significant (p<.01).
Although lower income was associated with lower QOL scores, this difference was not as
large in older survivors. The relationship between gender and QOL was only marginally
moderated by age in the final model (p=.08). Females had higher QOL scores than men, but
the difference was not as large in older survivors.
Discussion
The goals of this study were to explore the relationship of demographic and disease
characteristics to QOL and to determine the moderating effect of age on QOL among NHL
survivors. QOL was measured using FACT-G. Our study results are not consistent with the
Jerkeman et al. prospective study of lymphoma survivors who found non-significant
associations (2001), whereas we found significant associations between: 1) younger age and
decreased QOL; and 2) lower income and decreased QOL. The sample was evenly
distributed with numbers of males and females. While NHL is more common in older adults
than younger adults with an unpredictable illness trajectory, we found that younger survivors
had a more difficult time with their cancer diagnosis than older survivors. Breast cancer
survivorship literature has explored the impact of cancer in younger survivors more than any
other cancer and age has been shown as a moderator (Ganz et al, 2003; Kornblith et al,
2007); this is the first NHL study to our knowledge to explore age as a moderator on QOL.
We examined the moderating effect of age in these relationships and found age differences
in relationships between income and QOL. Younger NHLsurvivors (<65 years of age) with
lower income have poorer QOL compared to older NHL survivors. Females have higher
QOL than males.Time since diagnosis and the treatment period (e.g. active, surveillance)
may be contributing factors for either improved or decreased QOL in younger survivors and
female survivors. Younger NHL survivors are more likely to be of a minority race, with a
college degree, married or living with a partner, and having an annual income greater than
$30,000 than older NHL survivors (Bellizzi, Miller, Arora, & Rowland, 2001; Jerkeman,
Kassa, Hjermstad & Kvaloy, 2001; Smith, Zimmerman, Williams, Preisser & Clipp, 2008).
The association or influence of age on QOL was not fully described in these studies, but
sociodemographic characteristics were highly correlated. Leak et al (2011) review found
that older age was associated with worse physical QOL but better mental health compared to
younger adults with NHL. Additionally, older survivors who received chemotherapy had
poorer social and psychological wellbeing compared to those who did not receive
chemotherapy. The overall FACT-G score for this population was 85.3 (range 10–108),
which was higher than the normative data of the cancer sample. Emotional (19.6) and
functional well-being (20.7) were the lowest scored among the remaining 2 QOL domains
(physical and social/family).
Being female, a college graduate, employed, and having a longer time since diagnosis, were
all independently, positively associated with QOL. Whereas earning less than $30,000
annually, having higher comorbidities, currently receiving treatment, having had a
hematopoietic stem cell transplant or biologic therapy all had negative associations with
QOL. Often times, providers focus on the number of comorbidities, and less attention is
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focused on type, severity, and duration of the comorbidity. There are challenges posed by
multiple comorbidities and loss of function for patients at the time of diagnosis. Future work
is needed to explore the impact of comorbidities on QOL, with special attention to type of
comorbidity.
It has been well documented in the literature that lower socioeconomic status (SES) is
associated with lower QOL and poorer survival (Byers et al, 2008; Du, Fang & Meyer,
2008; Newman, Griffith, Jatoi, Simon, Crowe & Colditz, 2006). Younger survivors earning
less than $30,000 were associated with a lower QOL. Younger survivors often are diagnosed
at a time when they have multiple responsibilities (e.g., primary caregiver for their spouse,
parent, or child), working in or outside of the home, reproductive issues, and/or maintaining
their career aspirations. Additionally, younger survivors usually have fewer coping skills to
manage their diagnosis than older survivors and the thought of an early death may contribute
to greater distress and poorer QOL (Stanton, 2006; Thewes, Butow, Girgis & Pendlebury,
2004). Younger breast cancer survivors felt their diagnosis had limited their family, career,
and lifestyle priorities (Stewart et al, 2001; Thewes, Butow, Girgis, & Pendlebury, 2004).
Female survivors had higher QOL than male survivors with a marginal moderation by age.
These data are mixed in the literature, however most cancer studies focus on increased
coping skills (ie. cognitive restructuring) and support services for females with little
attention focused on males (Mattson, Demshar & Daly, 2012; Thewes, Butow, Girgis &
Pendlebury, 2004). Increasing social support systems and coping skills for males may
increase QOL to favorably impact overall survival that are both age and gender specific.
Limitations
This secondary analysis is cross sectional in nature so we cannot establish a cause-effect
relationship between demographic and disease characteristics and QOL, however we are
able to assess the strength of the associations. This population had a high education level
with 42% having a college degree and might have biased the findings. The strength of this
study is the use of an existing dataset of NHL survivors to answer questions about an
understudied cancer population. Future studies using other moderating effects on QOL such
as type of comorbidity and sociodemographic variables can provide additional information
about their associations with QOL. In addition, exploring the explanation for income
variances between younger and older survivors is warranted. Perhaps there is a need for a
more standardized approach to collecting demographic information. A longitudinal study
would provide a more definitive answer as to whether demographic and disease
characteristics differentially impact QOL changes with increasing age Future research is
needed to further explore male’s QOL and the impact of socioeconomic factors on
survivorship.
Implications for Nursing Practice
This study contributes to an important gap in the NHL literature about younger survivors
and the association between demographic characteristics and QOL. Despite limitations, this
study highlights the importance of considering age when trying to understand demographic
and disease characteristics and its relationship on QOL. Increasing age does not necessarily
mean that QOL will be lessened, and future studies are needed to look at age differences
across cancer populations with other sociodemographic and disease variables. Increasing
social support systems is one way to increase QOL to favorably impact overall survival in
younger survivors (Chou, Stewart, Bloom, & Koo, 2003). It alone, social support systems,
may not make a difference but nurses can effectively assess and refer patients to the most
appropriate resources. Understanding the buffering effect of age on QOL expands new
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avenues for targeting younger survivors. Further research is needed on optimizing resources
and services that could improve QOL for these survivors.
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Table 3
Age as a Moderator of the Relationship of Demographic and Disease Characteristics to Quality of Life
(FACT-G Score)
Characteristics Model 1: no moderation Model 2: moderation by age
B (SE) P value B (SE) P value
Demographic
  Age 0.29 <.0001 0.25 0.0004
Gender: Female 1.88 0.08 10.34 0.04
  Income: < $30,000 −6.03 <.0001 −24.11 <.0001
  College Graduate 2.48 0.056 2.71 0.04
  Employed 2.78 0.04 1.99 0.13
Disease
  Comorbidity Score −1.36 <.0001 −1.36 <.0001
  Currently Receiving −4.84 0.003 −4.92 0.002
  Treatment
  Cancer Treatments: −4.58 0.003 −4.87 0.002
  Bone Marrow
  Transplant
  Cancer Treatment: −2.68 0.04 −2.83 0.03
  Biologic
Years Since Diagnosis 0.16 0.048 0.13 0.11
  Female* Age - −0.14 0.08
  Income *Age - 0.28 0.001
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Table 4
Quality of Life Scores
QOL Range Mean Score Normative Data on
Cancer Samplea
FACT_G 10–108 85.3 80.9
FACT_PWB 0–28 22.7 21.3
FACT_SFWB 4–28 22.2 22.1
FACT_EWB 0–24 19.6 18.7
FACT_FWB 0–28 20.7 18.9
a
=FACT-G Normative data on cancer sample. David Cella, PhD, 2004
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